Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases

JAAD Case Rep. 2023 May 5:37:1-4. doi: 10.1016/j.jdcr.2023.04.025. eCollection 2023 Jul.

Rahul Masson¹, Justine Seivright², Terri Shih³, Richard G Bennett^{4

5

6}, Marcia Hogeling⁶, Vivian Y Shi⁷, Jennifer L Hsiao⁴

¹ Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
² Department of Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
³ David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
⁴ Department of Dermatology, University of Southern California, Los Angeles, California.
⁵ Bennett Surgery Center, Santa Monica, California.
⁶ Division of Dermatology, University of California Los Angeles, Los Angeles, California.
⁷ Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

No abstract available

Keywords: cephalexin; combination therapy; efficacy; hidradenitis suppurativa; outcomes; safety; treatment; trimethoprim/sulfamethoxazole.

Publication types